And insulin in human morbid weight problems. Int J Obes 1983, seven:529?38. Greenfield JR, Farooqi IS, Keogh JM, Henning E, Habib AM, Blackwood A, Reimann F, Holst JJ, Gribble FM: Oral glutamine increases circulating glucagon-like peptide one, glucagon, and insulin concentrations in lean, obese, and sort 2 diabetic topics. Am J Clin Nutr 2009, 89:106?13. Toft-Nielsen MB, Damholt MB, Madsbad S, Hilsted LM, Hughes TE, Michelsen BK, Holst JJ: Determinants on the impaired secretion of glucagon-like peptide-1 in sort 2 diabetic patients. J Clin Endocrinol Metab 2001, 86:3717?723. Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF, Haqq AM, Shah SH, Arlotto M, Slentz CA, et al: A branched-chain amino acid-related metabolic signature that differentiates obese and lean people and contributes to insulin resistance. Cell Metab 2009, 9:311?26. Naslund E, Gryback P, Backman L, Jacobsson H, Holst JJ, Theodorsson E, Hellstrom PM: Distal compact bowel hormones: correlation with fasting antroduodenal motility and gastric emptying. Dig Dis Sci 1998, 43:945?52. Verdich C, Toubro S, Buemann B, Lysgard Madsen J, Juul Holst J, Astrup A: The role of postprandial releases of insulin and incretin hormones in meal-induced satiety–effect of weight problems and excess weight reduction. Int J Obes Relat Metab Disord 2001, 25:1206?214.Formula of Platinum(IV) oxide 26. Verdich C, Flint A, Gutzwiller JP, Naslund E, Beglinger C, Hellstrom PM, Lengthy SJ, Morgan LM, Holst JJ, Astrup A: A meta-analysis with the impact of glucagon-like peptide-1 (7?6) amide on ad libitum energy intake in humans. J Clin Endocrinol Metab 2001, 86:4382?389. 27. Gutzwiller JP, Drewe J, Goke B, Schmidt H, Rohrer B, Lareida J, Beglinger C: Glucagon-like peptide-1 promotes satiety and lowers foods consumption in sufferers with diabetes mellitus kind 2.4-(Diethylphosphinyl)benzenamine Price Am J Physiol 1999, 276:R1541 1544.PMID:33534655 28. Zander M, Madsbad S, Madsen JL, Holst JJ: Result of 6-week program of glucagon-like peptide one on glycaemic manage, insulin sensitivity, and beta-cell perform in form 2 diabetes: a parallel-group study. Lancet 2002, 359:824?thirty. 29. Cahill F, Shea JL, Randell E, Vasdev S, Sun G: Serum peptide YY in response to short-term overfeeding in young males. Am J Clin Nutr 2011, 93:741?47. thirty. Mauriege P, Despres JP, Marcotte M, Tremblay A, Nadeau A, Moorjani S, Lupien P, Dussault J, Fournier G, Theriault G, et al: Adipose tissue lipolysis following long-term overfeeding in identical twins. Int J Obes Relat Metab Disord 1992, 16:219?25. 31. Shea J, Randell E, Vasdev S, Wang PP, Roebothan B, Sun G: Serum retinolbinding protein 4 concentrations in response to short-term overfeeding in normal-weight, obese, and obese males. Am J Clin Nutr 2007, 86:1310?315. 32. Sun G, Bishop J, Khalili S, Vasdev S, Gill V, Pace D, Fitzpatrick D, Randell E, Xie YG, Zhang H: Serum visfatin concentrations are positively correlated with serum triacylglycerols and down-regulated by overfeeding in healthy young men. Am J Clin Nutr 2007, 85:399?04. 33. Brons C, Jensen CB, Storgaard H, Hiscock NJ, White A, Appel JS, Jacobsen S, Nilsson E, Larsen CM, Astrup A, et al: Affect of short-term high-fat feeding on glucose and insulin metabolic process in younger nutritious men. J Physiol 2009, 587:2387?397. 34. Brand names M, Swat M, Lammers NM, Sauerwein HP, Endert E, Ackermans MT, Verhoeven AJ, Serlie MJ: Results of a hypercaloric food plan on beta-cell responsivity in lean wholesome men. Clin Endocrinol (Oxf ) 2012, 78(two):217?25. 35. He J, Votruba S, Pomeroy J, Bonfiglio S, Krakoff J: Measurement of ad libitum foods intake, bodily ac.